Request Your Free Infographic Now:

"Bring Advanced Therapies Closer to Home: Administering CGTs"

This infographic explores large-scale commercialization of CGTs and how hospitals and manufacturers can collaborate to improve patient access.

Cell and gene therapies (CGT) are moving into the mainstream, bringing new treatment options to patients with an array of diseases and conditions. However, expanding availability to more hospitals will require new ways to streamline delivery of these highly specialized treatments. CGT manufacturers can help hospitals become ready to introduce these new therapies.

This infographic covers areas where manufacturers can collaborate with hospitals to achieve more efficient workflows, fewer disruptions, and improved patient access for their CGTs. Certifying a hospital as an authorized treatment center is currently a time-consuming process, but it can be streamlined. Highlights include:

• The protocols and equipment requirements that hospitals may need to meet for CGT delivery, storage, preparation and administration.
• Considerations of managing cash flow for treatments that have up-front costs.
• The tech side hospitals need to know, including data collection and information security.

Offered Free by: BioPharma Dive's studioID and Cencora
See All Resources from: BioPharma Dive's studioID and Cencora